Banque Cantonale Vaudoise Boosts Holdings in Align Technology, Inc. (NASDAQ:ALGN)

Banque Cantonale Vaudoise grew its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 9.8% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,031 shares of the medical equipment provider’s stock after buying an additional 182 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Align Technology were worth $491,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the company. Mather Group LLC. acquired a new stake in Align Technology in the first quarter valued at about $26,000. LRI Investments LLC purchased a new stake in shares of Align Technology in the first quarter valued at approximately $29,000. Rothschild Investment LLC acquired a new position in shares of Align Technology during the 2nd quarter worth $26,000. Innealta Capital LLC acquired a new position in shares of Align Technology during the 2nd quarter worth $26,000. Finally, Versant Capital Management Inc increased its holdings in shares of Align Technology by 547.1% in the 2nd quarter. Versant Capital Management Inc now owns 110 shares of the medical equipment provider’s stock valued at $27,000 after purchasing an additional 93 shares in the last quarter. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Align Technology Trading Up 0.9 %

Shares of ALGN stock opened at $237.22 on Monday. The company has a market capitalization of $17.86 billion, a price-to-earnings ratio of 39.08, a PEG ratio of 5.40 and a beta of 1.66. The firm has a 50-day moving average price of $234.66 and a 200 day moving average price of $271.89. Align Technology, Inc. has a twelve month low of $176.34 and a twelve month high of $375.68.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Wednesday, July 24th. The medical equipment provider reported $2.41 earnings per share for the quarter, beating analysts’ consensus estimates of $2.32 by $0.09. Align Technology had a net margin of 11.34% and a return on equity of 14.07%. The business had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.04 billion. During the same quarter in the previous year, the business posted $1.73 earnings per share. The company’s revenue was up 2.6% on a year-over-year basis. As a group, research analysts predict that Align Technology, Inc. will post 7.61 earnings per share for the current year.

Insider Buying and Selling at Align Technology

In other Align Technology news, Director C Raymond Larkin, Jr. acquired 6,500 shares of the stock in a transaction dated Thursday, August 15th. The stock was acquired at an average price of $235.33 per share, with a total value of $1,529,645.00. Following the completion of the transaction, the director now directly owns 28,247 shares in the company, valued at $6,647,366.51. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.62% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on ALGN shares. Piper Sandler dropped their target price on shares of Align Technology from $330.00 to $315.00 and set an “overweight” rating for the company in a report on Thursday, July 25th. Evercore ISI reduced their price objective on Align Technology from $370.00 to $300.00 and set an “outperform” rating for the company in a report on Monday, June 10th. Morgan Stanley lowered their target price on Align Technology from $328.00 to $310.00 and set an “overweight” rating on the stock in a report on Thursday, July 25th. Stifel Nicolaus dropped their price target on Align Technology from $400.00 to $350.00 and set a “buy” rating for the company in a research report on Thursday, July 25th. Finally, OTR Global reiterated a “mixed” rating on shares of Align Technology in a research report on Tuesday, June 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $306.88.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.